A2A receptor agonist
This page covers all A2A receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting A2A receptor.
Targets
Phase 3 pipeline (1)
- Regadenoson central -central · Lokien van Nunen · Cardiovascular
Regadenoson central acts as an adenosine A2A receptor agonist, increasing coronary blood flow.